Clinical trial
Combination Chemotherapy in Treating Patients With Advanced Head and Neck Cancer
NCT00002888 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00002888 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Advanced Head and Neck Cancer |
| Official title | A RANDOMIZED PHASE III EVALUATION OF PACLITAXEL + G-CSF + CISPLATIN VERSUS CISPLATIN + 5-FU IN ADVANCED HEAD AND NECK CANCER |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH SWOG Cancer Research Network |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug |
| Interventions | cisplatin, fluorouracil, paclitaxel |
| Start date | Mar 1, 1997 |
| Completion | Aug 1, 2004 |
| First posted | Aug 24, 2004 |
| Last update posted | Jun 21, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: